Anderson Hoagland & Co’s Kite Pharma, Inc. KITE Stock Holding History

Anderson Hoagland & Co’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,335	Closed	-$600K	–	102
2017 Q3	$600K	Buy	+3,335	New	+$465K	0.37%	83

Anderson Hoagland & Co's KITE Position: Q4 2017 in Review

Anderson Hoagland & Co sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 3,335 shares — an estimated $600K sold.

Anderson Hoagland & Co first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $600K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Anderson Hoagland & Co reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Anderson Hoagland & Co sold 3,335 Kite Pharma, Inc. shares in Q4 2017, an estimated $600K.
Anderson Hoagland & Co first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
Anderson Hoagland & Co's Kite Pharma, Inc. position peaked at $600K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Anderson Hoagland & Co's 13F filing for Q4 2017, filed 18 Jan 2018.